statistiche ricercatore

DONADINI, MARCO PAOLO

Distribuzione geografica

Continente	#
NA - Nord America	6.097
EU - Europa	2.686
AS - Asia	2.012
SA - Sud America	234
AF - Africa	37
OC - Oceania	8
Continente sconosciuto - Info sul continente non disponibili	2
Totale	11.076

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.035
IT - Italia	1.330
SG - Singapore	670
CN - Cina	446
UA - Ucraina	372
HK - Hong Kong	274
VN - Vietnam	253
SE - Svezia	232
TR - Turchia	215
BR - Brasile	195
DE - Germania	174
IE - Irlanda	128
GB - Regno Unito	103
FR - Francia	102
FI - Finlandia	81
RU - Federazione Russa	73
IN - India	61
MX - Messico	39
NL - Olanda	23
CA - Canada	19
IQ - Iraq	16
AT - Austria	15
BD - Bangladesh	15
AR - Argentina	14
ES - Italia	14
PL - Polonia	14
JP - Giappone	11
NG - Nigeria	10
ZA - Sudafrica	9
AU - Australia	7
BE - Belgio	7
EC - Ecuador	7
TW - Taiwan	6
UZ - Uzbekistan	6
AE - Emirati Arabi Uniti	5
CL - Cile	5
CO - Colombia	5
AL - Albania	4
ID - Indonesia	4
MY - Malesia	4
PK - Pakistan	4
BO - Bolivia	3
CH - Svizzera	3
EG - Egitto	3
IL - Israele	3
KE - Kenya	3
SA - Arabia Saudita	3
TH - Thailandia	3
TN - Tunisia	3
BA - Bosnia-Erzegovina	2
BG - Bulgaria	2
CI - Costa d'Avorio	2
CR - Costa Rica	2
ET - Etiopia	2
EU - Europa	2
JO - Giordania	2
KG - Kirghizistan	2
LB - Libano	2
LT - Lituania	2
MA - Marocco	2
PT - Portogallo	2
VE - Venezuela	2
AM - Armenia	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
GR - Grecia	1
HR - Croazia	1
IR - Iran	1
KH - Cambogia	1
KZ - Kazakistan	1
LK - Sri Lanka	1
MU - Mauritius	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PE - Perù	1
PH - Filippine	1
PY - Paraguay	1
TT - Trinidad e Tobago	1
TZ - Tanzania	1
UY - Uruguay	1
Totale	11.076

Salva come PNG Salva come JPEG

Città	#
Milan	895
Fairfield	799
Woodbridge	497
Ashburn	495
Singapore	390
San Jose	368
Houston	354
Seattle	323
Wilmington	282
Chandler	280
Ann Arbor	270
Hong Kong	270
Jacksonville	270
Cambridge	240
The Dalles	130
Izmir	126
Dublin	124
Princeton	123
Chicago	119
Dallas	117
Dearborn	92
Nyköping	87
Los Angeles	86
Boardman	84
Beijing	79
Dong Ket	70
Rome	70
Lauterbourg	69
San Diego	47
Council Bluffs	46
Ho Chi Minh City	39
New York	36
London	34
Ogden	33
Hanoi	32
Mexico City	29
Salt Lake City	25
Guangzhou	24
Helsinki	24
Santa Clara	22
Tampa	19
San Mateo	18
Afragola	17
Como	17
Orem	17
São Paulo	16
Elk Grove Village	15
Chennai	14
Frankfurt am Main	14
Shanghai	14
Varese	14
Denver	13
Hangzhou	11
Nuremberg	11
Schiffdorf	11
Manchester	10
San Francisco	10
Warsaw	10
Abuja	9
Düsseldorf	9
Falkenstein	9
Hefei	9
Montreal	9
Phoenix	9
Tokyo	9
Washington	9
Buffalo	8
Cavaria con Premezzo	8
Columbus	8
Kunming	8
Miami	8
Nanjing	8
Ralingen	8
Amsterdam	7
Bangalore	7
Brooklyn	7
Brussels	7
Dulles	7
Haiphong	7
Johannesburg	7
Lancaster	7
Munich	7
Olgiate Olona	7
Redmond	7
Shenzhen	7
Sterling	7
Stockholm	7
Tianjin	7
Baghdad	6
Belo Horizonte	6
Campinas	6
Jinan	6
Norwalk	6
Redwood City	6
Tashkent	6
Verona	6
Boston	5
Da Nang	5
Detroit	5
Fuzhou	5
Totale	8.052

Salva come PNG Salva come JPEG

Nome	#
Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: a Delphi analysis of experts	401
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	292
Risk of recurrence of unusual site venous thromboembolism	252
Optimal treatment duration of venous thrombosis	247
Breadth of complications of long-term oral anticoagulant care	241
Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients	233
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	228
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	220
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	215
Patient selection for thromboprophylaxis in medical inpatients	214
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	211
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	207
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	201
Treating patients with cancer and acute venous thromboembolism	197
Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation	196
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	195
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events	188
Antidotes for the direct oral anticoagulants: What news?	188
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	186
Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study).	186
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies	182
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	182
Pulmonary Embolism in Medical-Surgical Critically Ill Patients	182
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events	179
Brand name versus generic warfarin: a systematic review of the literature.	174
Clinical approach to splanchnic vein thrombosis: Risk factors and treatment.	171
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm	171
Retrievable vena cava filters: a clinical review.	170
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging.	169
Splanchnic vein thrombosis: new risk factors and management	169
Should alcohol be considered a minor protective factor for unprovoked venous thromboembolism?	165
Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations	160
Efficacy and safety of dabigatran etexilate: a narrative review	158
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors	154
Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis.	153
JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis	146
Incidence of symptomatic and asymptomatic chronic pulmonary hypertension in patients with a previous episode of pulmonary embolism: a prospective cohort study	143
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis	143
Which patients with unprovoked VTE should receive extended anticoagulation? the minority.	142
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?	139
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET)	136
The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study.	131
Trattamento del tromboembolismo venoso con anticoagulanti tradizionali e di nuova generazione.	129
Prediction scores do not correlate with clinically adjudicated categories of pulmonary embolism in critically ill patients	128
PROPOSAL FOR THE INCLUSION OF LOW MOLECULAR WEIGHT HEPARINS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS IN THE WHO MODEL LIST OF ESSENTIAL MEDICINES	124
Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience	122
Venous thromboembolism: pathophysiology, diagnosis and prophylaxis	116
Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review	111
Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)	110
null	109
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation	101
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.	94
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound A Systematic Review and Meta-analysis	92
Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach	91
Anticoagulant treatment for Upper Extremity Deep Vein thrombosis: a systematic review and meta-analysis	91
Splanchnic vein thrombosis	88
Unusual site thrombosis.	85
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism	84
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants	83
Manuale di emergenze medico-chirurgiche	82
Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study	78
Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis	76
La trombosi venosa profonda e l’embolia polmonare	76
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis	74
Perioperative Management of Patients who are Receiving Oral Anticoagulant Therapy	70
Initial and Long-Term Treatment of Pulmonary Embolism: Current Approach and Future Perspectives	69
Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon?	65
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients	62
Development of personalized thrombogenesis and thrombin generation assays to assess endothelial dysfunction in cardiovascular diseases	61
Steps towards simplifying the treatment of pulmonary embolism	61
Expert-Based Narrative Review on Compression UltraSonography (CUS) for Diagnosis and Follow-Up of Deep Venous Thrombosis (DVT)	60
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	57
Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis	57
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?	56
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review	54
DOACs use in extreme body-weighted patients: results from the prospective START-register	48
Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem	47
The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction?	46
Drug–drug interactions between DAAs and anticoagulants or antiplatelets: a position paper of the italian anticoagulation clinics	43
The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial	40
Geographical and ethnoracial differences in venous thromboembolism and anticoagulation: An expanding horizon	40
Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis	39
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study	30
Venous Thromboembolism Risk Associated with MIDLINE Catheters and Peripherally Inserted Central Catheters, a Systematic Review and Meta-Analysis	12
Implementing anticoagulation stewardship: the use of a dedicated mobile phone ‘app’ in the experience of the Italian Federation of Anticoagulation linics (FCSA)	10
Thrombotic events after vaccination for covid-19 in Italy: a report from the Italian society on thrombosis and haemostasis registry	8
Distal deep vein thrombosis: is there a way out of this dark forest?	6
Results from an Expert-Based Cross-Sectional National Survey on Antithrombotic TREATment After PEDiatric Peripheral Vascular Injuries. (The TREAT-PED-PVI Survey)	5
Exploring Italian nursing staff in anticoagulation clinics: a cluster-based description of current practice, nurse self-efficacy, job satisfaction, and interprofessional collaboration	1
Totale	11.208

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	43.077
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	43.077

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	327	0	0	0	0	0	0	0	0	0	75	114	138
2021/2022	758	98	116	21	36	58	36	33	50	43	123	64	80
2022/2023	760	78	64	28	96	57	158	10	84	123	26	19	17
2023/2024	1.432	244	234	227	274	278	60	2	26	60	8	18	1
2024/2025	1.380	8	12	187	18	19	89	58	90	90	107	297	405
2025/2026	2.631	231	141	142	304	214	230	562	220	410	177	0	0
Totale													11.208